Market Cap (In ILA)
159.8 Million
Revenue (In ILA)
321.66 Million
Net Income (In ILA)
-6.91 Million
Avg. Volume
1090.00
- Currency
- ILA
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1167.0-1601.0
- PE
- -
- EPS
- -
- Beta Value
- 0.055
- ISIN
- IL0010810096
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Mordechai Elgrabli
- Employee Count
- -
- Website
- https://www.rekah.co.il
- Ipo Date
- 2002-08-12
- Details
- Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of prescription and OTC drugs, dermo-cosmetics, vitamins, and nutritional supplements in Israel. The company offers steroid tablets; antibiotics, including penicillin and cephalosporin; drops and ointments to treat allergies, infections, and dryness of the eyes; baby products; and dermatological preparations. Its portfolio of products comprise approximately 280 drugs used in various medical fields. Rekah Pharmaceutical Industry Ltd. was founded in 1941 and is based in Holon, Israel.
More Stocks
-
0K5RNavient Corporation
0K5R
-
AMEAMETEK, Inc.
AME
-
AMCRAmcor plc
AMCR
-
DRVN
-
PUR
-
TTTTitomic Limited
TTT
-
YEXTYext, Inc.
YEXT
-
MACFMacfarlane Group PLC
MACF